Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Januario E Castro

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Best Practice & Research. Clinical Haematology|October 16, 2016
Adoptive cellular therapy for chronic lymphocytic leukemia and B cell malignancies. CARs and moreJanuario E Castro, Thomas J Kipps
Cancer Treatment and Research|March 23, 2002
Development of allogeneic hematopoietic stem cell transplantation (HSCT)Januario E Castro, Edward D Ball
Journal of Medicinal Chemistry|March 29, 2014
Potent fluorinated agelastatin analogues for chronic lymphocytic leukemia: design, synthesis, and pharmacokinetic studiesE Paige Stout, Michael Y Choi, Januario E Castro, et al.
Human Gene Therapy|November 11, 2014
Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regressionMauricio Urquiza, Johanna Melo-Cardenas, Robier Aguillon, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2011
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cellsDesheng Lu, Michael Y Choi, Jian Yu, et al.
Frontiers in Oncology|September 18, 2023
ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotypeEider Moreno-Cortes, Pedro Franco-Fuquen, Juan E Garcia-Robledo, et al.
Current Oncology Reports|November 6, 2022
Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider's PerspectiveGinna Granroth, Allison Rosenthal, Maggie McCallen, et al.
Blood|June 24, 2005
ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemiaJanuario E Castro, Carlos E Prada, Olivier Loria, et al.
Cancer Research|April 17, 2012
Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 moleculeJanuario E Castro, Johanna Melo-Cardenas, Mauricio Urquiza, et al.
Journal of Medicinal Chemistry|August 8, 2013
Stabilized cyclopropane analogs of the splicing inhibitor FD-895Reymundo Villa, Manoj Kumar Kashyap, Deepak Kumar, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Best Practice & Research. Clinical Haematology|October 16, 2016
Adoptive cellular therapy for chronic lymphocytic leukemia and B cell malignancies. CARs and moreJanuario E Castro, Thomas J Kipps
Cancer Treatment and Research|March 23, 2002
Development of allogeneic hematopoietic stem cell transplantation (HSCT)Januario E Castro, Edward D Ball
Journal of Medicinal Chemistry|March 29, 2014
Potent fluorinated agelastatin analogues for chronic lymphocytic leukemia: design, synthesis, and pharmacokinetic studiesE Paige Stout, Michael Y Choi, Januario E Castro, et al.
Human Gene Therapy|November 11, 2014
Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regressionMauricio Urquiza, Johanna Melo-Cardenas, Robier Aguillon, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2011
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cellsDesheng Lu, Michael Y Choi, Jian Yu, et al.
Frontiers in Oncology|September 18, 2023
ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotypeEider Moreno-Cortes, Pedro Franco-Fuquen, Juan E Garcia-Robledo, et al.
Current Oncology Reports|November 6, 2022
Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider's PerspectiveGinna Granroth, Allison Rosenthal, Maggie McCallen, et al.
Blood|June 24, 2005
ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemiaJanuario E Castro, Carlos E Prada, Olivier Loria, et al.
Cancer Research|April 17, 2012
Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 moleculeJanuario E Castro, Johanna Melo-Cardenas, Mauricio Urquiza, et al.
Journal of Medicinal Chemistry|August 8, 2013
Stabilized cyclopropane analogs of the splicing inhibitor FD-895Reymundo Villa, Manoj Kumar Kashyap, Deepak Kumar, et al.
Pageof 5